Ipamorelin/Tesamorelin Blend 15mg

Research Specifications

Components:
Ipamorelin 5mg + Tesamorelin 10mg (15mg total)
Form:
Lyophilized co-formulation
Purity:
≥98% HPLC verified (each component)
Vial:
15mg blend
Storage:
−20°C long-term / 2–8°C up to 4 weeks reconstituted

Ipamorelin/Tesamorelin Blend 15mg

Trans-3-hexenoyl-GHRH(1-44)-NH2

CAS: 218949-48-5

5mg + 10mg

Per-component mass

15mg total blend

1:2 ratio

Ipa:Tesa mass ratio

Extended-protocol weighted

2010

Tesamorelin FDA approval

Egrifta label

Receptor Targets

GHRH-RTesamorelin component — FDA-validated GH release
GHSR (Ghrelin-R)Ipamorelin component — selective pulsatile release
$134.99In Stock
Buy Now
≥98% Purity Verified Free Shipping $200+ HPLC Tested

Also Known As

Ipa/Tesa blend 15mgTesamorelin + Ipamorelin stack

Reconstitution & Dosing Guide

BAC Water

2mL

Final Concentration

7.5 mg/mL total (2.5 mg/mL Ipa + 5 mg/mL Tesa)

Per Dose

0.4 mL = ~1 mg Ipa + ~2 mg Tesa

Pre-sleep dosing aligns with natural nocturnal GH pulse

Published References

  1. 1.
    Falutz J, Allas S, Blot K, et al.. Metabolic effects of a growth hormone–releasing factor in patients with HIV. NEJM (2007) PMID: 18032764
  2. 2.
    Raun K, Hansen BS, Johansen NL, et al.. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology (1998) PMID: 9700374

Research Use Only. This product is intended for in-vitro laboratory research only. Not for human consumption, injection, or therapeutic use. Not medical advice. Always consult applicable regulations in your jurisdiction.

Price Comparison

SupplierPurityPriceShipping
our verified supplier>98% HPLC$134.99Free over $200
Generic Research SuppliersVaries (often <95%)Similar–HigherVaries
Pharmaceutical (Rx only)Pharmaceutical gradeNot available for researchRx required

Ipamorelin/Tesamorelin Blend 15mg

$134.99

Buy Now